Institutional Repository of Vilnius University
EGFR ir ALK genų mutacijų paplitimas nesmulkiųjų ląstelių plaučių vėžiu sergančių pacientų populiacijoje /
Abstract
dc:descriptionLung cancer is the world's first most common cancer and the leading cause of cancer-related death. The most common histological form of lung cancer is non-small cell lung cancer (NSCLC), which can be treated with targeted therapies. The main predictive markers for NSCLC are mutations in the epidermal growth factor receptor gene (EGFR) and the anaplastic lymphoma kinase gene (ALK). The frequency of mutations in these genes varies in different countries; therefore, this study aimed to investigate the prevalence of EGFR and ALK mutations in a population of Lithuanian patients with NSCLC and to compare the observed frequencies with the literature data. The recent algorithms for the testing of NSCLC predictive markers, the specificity of EGFR and ALK mutations, and the pathological molecular mechanisms they causeare discussed.The work included the detection of EGFR mutations in exons 18-21 by real-time PCR and ALK gene mutation by immunohistochemistry and fluorescence in situ hybridization methods. The frequency of EGFR mutations in NSCLC patients was found to be 20,16 %. EGFR mutations were found more frequently inwomenthaninmen(p<0.0001).TheprevalenceofALKmutationinNSCLCpatientswas5,14 %. ALK mutations were more prevalent in younger patients (≤68 years) than in older patients (>68 years) (p = 0.0177). These findings are in agreement with the literature.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Groblytė, Akvilė,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD210637582&prefLang=en_US